ARTICLE | Financial News
ImmunoCellular adds $21M
October 19, 2012 1:28 AM UTC
ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC) raised $21 million through the sale of 10 million shares at $2.10 in a follow-on underwritten by Lazard; Roth Capital Partners; Maxim; and Summer Street....